121
Participants
Start Date
November 7, 2007
Primary Completion Date
April 3, 2012
Study Completion Date
April 3, 2012
zoledronic acid
Zoledronic acid concentrate (4 mg/5 milliliters \[ml\]) was diluted in 100 mL sterile 0.9% calcium-free sodium chloride or 5% dextrose injection, administered IV, either 4 or 12 weeks for 96 weeks.
SUNY - Upstate Medical University Div. of Hematology-Oncology, Syracuse
Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center, Rochester
University of Rochester MC / James P. Wilmot Cancer Center James P. Wilmot Cancer Center, Rochester
Regional Hematology-Oncology Associates PC, Langhorne
Temple University Temple University, Philadelphia
Washington Hospital Center, Washington D.C.
Oncology - Hematology Associates, PA Oncology Hematology Assoc, Clinton
Center for Cancer & Blood Disorders, Bethesda
University of Maryland Greenebaum Cancer Center, Baltimore
Peninsula Cancer Institute, Newport News
West Virginia University Health Research Center Clinical Trial Research Unit, Morgantown
Carolina Oncology Specialists, PC, Hickory
Lexington Oncology Associates, West Columbia
Medical Associates, PA, Charleston
Low Country Hematology Oncology Dept of Lowcountry Hem/Onc, Mt. Pleasant
Integrated Community Oncology Network Florida Oncology Associates, Orange Park
Innovative Medical Research of South Florida Innovative Med Research, Miami Shores
Cleveland Clinic Florida, Weston
Palm Beach Institute of Hematology Oncology, Boynton Beach
N MS Hematology & Oncology, Tupelo
Avera Research Institute, Sioux Falls
Loyola University Medical Center /Cardinal Bernardin Cancer Loyola Univ Med Ctr, Maywood
Blood and Cancer Center of East Texas, Tyler
East Texas Medical Center Cancer Institute, Tyler
University of Colorado U of Colorado Cancer Center, Aurora
Central Utah Clinic Central Utah Clinic (8), Provo
TriValley Cancer Research and Treatment Center, Casa Grande
Cedars Sinai Medical Center Outpatient Cancer Ctr. (4), Los Angeles
Wilshire Oncology Medical Group, La Verne
Oncology Care Medical Associates, San Gabriel
Palo Alto Medical Foundation Hematology/Oncology, Mountain View
Santa Clara Valley Health & Hospital System, San Jose
Swedish Cancer Institute, Seattle
Hematology Oncology PC, Stamford
Cancer Centers of Florida PA Cancer Centers of Central FL, Ocoee
Dana Farber Cancer Institute Clinical Research Coordinator, Boston
Boston VA Healthcare Boston VA, Boston
Berkshire Hematology Oncology, Pittsfield
Hematology & Oncology Consultants, PC Hematology & Oncology, Omaha
Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2), Somerset
Cooper Cancer Center, Voorhees Township
Northern Utah Cancer Associates Dept.ofNorthernUtahAssoc., Ogden
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY